Relma-Cel Continues to Elicit Responses in Chinese Patients With R/R Mantle Cell Lymphoma
Relmacabtagene autoleucel continued to induce responses with acceptable tolerability in Chinese patients with relapsed or refractory mantle cell lymphoma.
Source: onclive.com